Zobrazeno 1 - 9
of 9
pro vyhledávání: '"SREENIVASAN, SUSHANTH"'
Autor:
Chitkara, Akshit1 (AUTHOR) akshit.chitkara@jefferson.edu, Sreenivasan, Sushanth2 (AUTHOR) sushanth.sreenivasan@ahn.org, Yin, Yue3 (AUTHOR) yue.yin@ahn.org, Rai, Maitreyee4 (AUTHOR) santhosh.sadashiv@ahn.org, Sadashiv, Santhosh4 (AUTHOR)
Publikováno v:
Current Oncology. Aug2024, Vol. 31 Issue 8, p4338-4345. 8p.
Publikováno v:
Cancer Diagn Progn
Background/Aim: Primary testicular lymphoma (PTL) is an exceedingly rare and aggressive form of non-Hodgkin’s lymphoma; the most common subtype is diffuse large B-cell (DLBCL). Standard treatment includes orchiectomy, chemotherapy, central nervous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a0194bada874b117770b560105b4a0
https://doi.org/10.21873/cdp.10192
https://doi.org/10.21873/cdp.10192
Primary CNS lymphoma (PCNSL) is an aggressive form of extranodal non-Hodgkin lymphoma that arises in the brain parenchyma, eyes, meninges, or spinal cord in the absence of systemic disease. Primary dural lymphoma (PDL) arises from the dura mater of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::185279a12416a1629447cf7463ec4093
https://doi.org/10.21203/rs.3.rs-2610064/v1
https://doi.org/10.21203/rs.3.rs-2610064/v1
Publikováno v:
In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S75-S75
Autor:
Sreenivasan, Sushanth *, Shah, Shivani *, Solanki, Risha *, Kancharla, Pragnan, Lister, John, Khan, Cyrus, Samhouri, Yazan
Publikováno v:
In Blood 15 November 2022 140 Supplement 1:11995-11996
Publikováno v:
In Chest October 2020 158(4) Supplement:A1562-A1562
Publikováno v:
Journal of Clinical & Diagnostic Research; Jan2016, Vol. 10 Issue 1, p4-6, 3p
Autor:
Lerner L; College of Medicine, Unit K, Drexel University, Philadelphia, PA, USA.; These authors contributed equally to this article., Sreenivasan S; Department of Medicine, Allegheny General Hospital, Pittsburgh, PA, USA.; These authors contributed equally to this article., Peterson C; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Rai M; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Kancharla P; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Santosa S; Division of Pathology, Allegheny General Hospital, Pittsburgh, PA, USA., Bunker M; Division of Pathology, Allegheny General Hospital, Pittsburgh, PA, USA., Samhouri Y; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
Publikováno v:
Journal of hematology [J Hematol] 2024 Oct; Vol. 13 (5), pp. 229-237. Date of Electronic Publication: 2024 Oct 03.
Autor:
Sreenivasan S; Department of Internal Medicine, West Penn Hospital, Pittsburgh, PA, USA., Solanki R; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Kancharla P; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Khan C; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Samhouri Y; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
Publikováno v:
Journal of hematology [J Hematol] 2023 Apr; Vol. 12 (2), pp. 87-91. Date of Electronic Publication: 2023 Apr 30.